After Hours
$
8.05
Change
0.00 0.00%
Volume
Volume 2,454
May 27, 2022, 4:43 p.m.
Quotes are delayed by 20 min
Today's close
$ 7.94
$ 8.05
Change
+0.11 +1.39%
Day low
Day high
$7.60
$8.18

52 week low
52 week high
$7.59
$81.19

Market cap
$323.01M
Average volume
363,035
P/E ratio
N/A
Rev. per Employee
N/A
EPS
-2.32
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on ALXO
-
ALX Oncology stock price target cut to $36 from $60 at Stifel Nicolaus
- Tomi Kilgore
-
ALX Oncology initiated at buy with $106 target price at Stifel
- Tonya Garcia
-
ALX Oncology started at buy with $96 stock price target at UBS
- Tomi Kilgore
-
Biotech stocks are a buy — especially these 18 picks
- Michael Brush
-
ALX Oncology sets IPO terms, to raise up to $136 million
- Tomi Kilgore
Other News on ALXO
-
ALX Oncology files for $450 mixed shelf offering
- Seeking Alpha
-
10-K: ALX ONCOLOGY HOLDINGS INC
- Edgar Online - (EDG = 10Q, 10K)
-
ALX Oncology Is Turning Into An Also-Ran In Anti-CD47
- Seeking Alpha
-
New Strong Sell Stocks for January 19th
- Zacks.com
-
ALX Oncology plunges as director sells shares worth $75M
- Seeking Alpha
-
ALX Oncology under pressure as director sells shares worth $4.7M
- Seeking Alpha
-
RENN, VIOT and IGMS among mid-day movers
- Seeking Alpha
-
ALX Oncology Holdings (ALXO) Investor Presentation
- Seeking Alpha
-
10-Q: ALX ONCOLOGY HOLDINGS INC
- Edgar Online - (EDG = 10Q, 10K)
-
Warning: ALXO is at high risk of performing badly
- Seeking Alpha
-
AGC, QUBT and BTB among mid-day movers
- Seeking Alpha
-
JP, HCDI and PETZ among mid-day movers
- Seeking Alpha
- Loading more headlines...
Press Releases on ALXO
-
Gastrointestinal Cancer Treatment Trials Driven by Rising Incidences of Colorectal Cancer
- Financial News Media
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com